One-year net survival (NS, %) overall, age-standardised and age-specific, by stage at diagnosis and country for patients with small cell lung cancer diagnosed during 2004–2007
| Australia* | Canada† | Denmark | Norway | Sweden‡ | UK§ | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NS (%) | 95% CI | NS (%) | 95% CI | NS (%) | 95% CI | NS (%) | 95% CI | NS (%) | 95% CI | NS (%) | 95% CI | |
| TNM stage | ||||||||||||
| All patients | ||||||||||||
| All ages | 30.7 | 28.3 to 33.0 | 30.8 | 29.1 to 32.5 | 36.1 | 32.9 to 39.3 | 24.7 | 23.3 to 26.1 | ||||
| Age-standardised | 30.0 | 28.0 to 32.1 | 30.6 | 29.1 to 32.0 | 36.6 | 33.8 to 39.4 | 24.9 | 23.7 to 26.1 | ||||
| 15–54 | 44.6 | 38.1 to 51.0 | 41.2 | 36.2 to 46.1 | 48.9 | 38.6 to 59.3 | 33.2 | 29.1 to 37.3 | ||||
| 55–74 | 32.9 | 30.1 to 35.8 | 33.9 | 31.9 to 36.0 | 39.2 | 35.4 to 43.0 | 27.9 | 26.2 to 29.6 | ||||
| 75–99 | 17.5 | 14.0 to 20.9 | 18.1 | 15.7 to 20.5 | 26.0 | 21.1 to 30.8 | 14.4 | 12.5 to 16.2 | ||||
| Stage I and II | ||||||||||||
| All ages | 71.7 | 60.4 to 83.1 | 65.2 | 56.5 to 73.9 | 70.3 | 56.7 to 83.9 | 56.0 | 48.7 to 63.4 | ||||
| Age-standardised | 71.1 | 61.5 to 80.7 | 64.5 | 57.1 to 71.9 | 71.7 | 59.8 to 83.7 | 55.9 | 49.6 to 62.2 | ||||
| 15–54 | 94.9 | 88.6 to 100.0 | 82.6 | 66.9 to 98.4 | 99.9 | 99.6 to 100.0 | 82.2 | 70.5 to 93.8 | ||||
| 55–74 | 77.2 | 65.0 to 89.4 | 71.7 | 61.8 to 81.5 | 72.5 | 55.4 to 89.6 | 57.3 | 48.7 to 65.9 | ||||
| 75–99 | 48.6 | 25.7 to 71.6 | 44.6 | 29.3 to 59.9 | 60.0 | 38.6 to 81.4 | 44.9 | 32.4 to 57.5 | ||||
| Stage III | ||||||||||||
| All ages | 48.5 | 43.8 to 53.1 | 51.0 | 46.8 to 55.3 | 51.6 | 45.0 to 58.1 | 36.9 | 32.8 to 41.0 | ||||
| Age-standardised | 47.9 | 43.9 to 52.0 | 50.6 | 47.1 to 54.2 | 52.2 | 46.6 to 57.8 | 37.3 | 33.9 to 40.7 | ||||
| 15–54 | 71.0 | 59.6 to 82.3 | 74.3 | 66.3 to 82.3 | 63.0 | 45.4 to 80.5 | 50.8 | 40.5 to 61.0 | ||||
| 55–74 | 51.1 | 45.6 to 56.7 | 52.7 | 47.8 to 57.7 | 54.7 | 47.0 to 62.4 | 42.2 | 37.3 to 47.1 | ||||
| 75–99 | 29.4 | 21.9 to 36.9 | 35.3 | 28.4 to 42.1 | 41.6 | 31.4 to 51.8 | 18.8 | 13.1 to 24.5 | ||||
| Stage IV | ||||||||||||
| All ages | 18.3 | 15.8 to 20.8 | 23.0 | 21.1 to 24.9 | 26.8 | 23.0 to 30.6 | 14.4 | 12.7 to 16.2 | ||||
| Age-standardised | 17.9 | 16.1 to 19.8 | 23.0 | 21.5 to 24.4 | 27.6 | 24.6 to 30.6 | 14.4 | 13.1 to 15.8 | ||||
| 15–54 | 31.5 | 25.6 to 37.4 | 35.5 | 31.0 to 39.9 | 39.4 | 30.1 to 48.7 | 19.9 | 15.8 to 24.0 | ||||
| 55–74 | 18.7 | 16.1 to 21.3 | 23.8 | 21.8 to 25.7 | 28.6 | 24.5 to 32.8 | 14.7 | 12.9 to 16.5 | ||||
| 75–99 | 10.0 | 7.1 to 13.0 | 15.0 | 12.3 to 17.7 | 19.5 | 13.9 to 25.2 | 11.1 | 8.7 to 13.6 | ||||
| Missing stage | ||||||||||||
| All ages | 20.5 | 6.1 to 35.0 | 23.2 | 17.9 to 28.6 | 16.9 | 5.4 to 28.4 | 24.4 | 22.3 to 26.6 | ||||
| Age-standardised | 23.0 | 13.6 to 32.4 | 24.3 | 20.7 to 27.9 | 16.8 | 9.5 to 24.2 | 24.2 | 22.4 to 26.1 | ||||
| 15–54 | Not possible to estimate | 38.2 | 29.2 to 47.2 | 29.3 | 14.0 to 44.5 | 38.2 | 30.8 to 45.6 | |||||
| 55–74 | 25.7 | 9.7 to 41.7 | 27.3 | 21.3 to 33.3 | 21.1 | 7.8 to 34.4 | 28.0 | 25.3 to 30.8 | ||||
| 75–99 | 13.3 | 0.9 to 25.7 | 14.3 | 9.4 to 19.2 | 7.9 | 0.0 to 16.1 | 13.7 | 11.0 to 16.4 | ||||
| SEER Summary Stage 2000 | ||||||||||||
| All patients | ||||||||||||
| All ages | 37.5 | 35.0 to 39.9 | 32.9 | 30.4 to 35.5 | 33.4 | 31.6 to 35.2 | 33.4 | 31.2 to 35.5 | 38.2 | 34.8 to 41.5 | 23.9 | 20.1 to 27.6 |
| Age-standardised | 38.6 | 36.5 to 40.6 | 32.3 | 30.2 to 34.4 | 33.1 | 31.5 to 34.6 | 33.3 | 31.4 to 35.1 | 38.7 | 35.8 to 41.5 | 23.1 | 19.9 to 26.4 |
| 15–54 | 54.5 | 48.3 to 60.6 | 46.7 | 40.2 to 53.2 | 43.8 | 38.8 to 48.9 | 54.2 | 48.1 to 60.2 | 51.2 | 40.9 to 61.4 | 34.5 | 25.5 to 43.6 |
| 55–74 | 41.6 | 38.6 to 44.5 | 35.2 | 32.2 to 38.2 | 36.4 | 34.3 to 38.6 | 37.2 | 34.4 to 39.9 | 41.3 | 37.3 to 45.2 | 24.3 | 19.8 to 28.8 |
| 75–99 | 24.8 | 21.3 to 28.2 | 19.8 | 16.1 to 23.5 | 20.7 | 18.1 to 23.2 | 16.7 | 14.0 to 19.5 | 28.0 | 22.9 to 33.0 | 15.3 | 9.4 to 21.2 |
| Localised | ||||||||||||
| All ages | 53.7 | 48.2 to 59.1 | 74.4 | 61.9 to 86.9 | 60.8 | 49.8 to 71.7 | 65.9 | 55.5 to 76.2 | 72.4 | 56.5 to 88.4 | 43.6 | 23.7 to 63.5 |
| Age-standardised | 53.0 | 49.0 to 57.0 | 75.8 | 67.8 to 83.7 | 61.7 | 54.6 to 68.7 | 65.9 | 59.1 to 72.6 | 74.0 | 64.1 to 83.9 | 41.2 | 27.9 to 54.5 |
| 15–54 | 77.2 | 70.1 to 84.3 | 90.4 | 84.1 to 96.6 | 80.9 | 72.8 to 89.0 | 83.8 | 76.7 to 90.9 | 90.0 | 82.6 to 97.4 | 74.0 | 58.7 to 89.4 |
| 55–74 | 57.9 | 52.1 to 63.8 | 78.6 | 67.3 to 89.8 | 65.5 | 55.0 to 75.9 | 68.8 | 58.9 to 78.8 | 77.1 | 63.1 to 91.2 | 44.1 | 22.7 to 65.5 |
| 75–99 | 35.1 | 27.3 to 42.8 | 62.2 | 44.5 to 79.9 | 46.5 | 32.5 to 60.4 | 52.8 | 39.1 to 66.5 | 62.3 | 41.3 to 83.2 | 24.3 | 2.9 to 45.8 |
| Regional | ||||||||||||
| All ages | 35.4 | 29.2 to 41.5 | 50.6 | 44.9 to 56.2 | 54.0 | 48.6 to 59.5 | 50.7 | 45.8 to 55.5 | 56.6 | 47.8 to 65.3 | 51.0 | 34.0 to 67.9 |
| Age-standardised | 37.2 | 31.8 to 42.6 | 50.1 | 45.4 to 54.8 | 54.1 | 49.6 to 58.6 | 49.3 | 45.1 to 53.4 | 57.4 | 50.1 to 64.8 | 51.9 | 37.0 to 66.7 |
| 15–54 | 52.1 | 36.1 to 68.2 | 74.7 | 63.2 to 86.2 | 70.2 | 59.3 to 81.1 | 75.2 | 66.0 to 84.4 | 71.7 | 51.1 to 92.2 | 76.5 | 41.1 to 100.0 |
| 55–74 | 41.1 | 33.3 to 48.9 | 53.9 | 47.3 to 60.4 | 56.3 | 50.2 to 62.4 | 55.1 | 49.1 to 61.0 | 60.2 | 50.0 to 70.4 | 59.1 | 36.4 to 81.8 |
| 75–99 | 19.7 | 11.1 to 28.2 | 30.1 | 21.5 to 38.7 | 41.6 | 32.2 to 50.9 | 25.4 | 17.5 to 33.2 | 44.8 | 31.2 to 58.5 | 22.0 | 0.7 to 43.3 |
| Distant | ||||||||||||
| All ages | 19.8 | 17.1 to 22.4 | 23.4 | 20.7 to 26.1 | 28.8 | 26.8 to 30.7 | 22.9 | 20.5 to 25.3 | 32.1 | 28.5 to 35.8 | 14.1 | 9.6 to 18.6 |
| Age-standardised | 20.9 | 18.5 to 23.3 | 22.8 | 20.5 to 25.0 | 28.4 | 26.7 to 30.0 | 23.3 | 21.2 to 25.4 | 32.6 | 29.5 to 35.8 | 14.0 | 9.9 to 18.1 |
| 15–54 | 31.3 | 22.2 to 40.4 | 37.5 | 30.2 to 44.7 | 40.3 | 34.7 to 45.9 | 40.1 | 32.0 to 48.3 | 38.7 | 27.4 to 50.0 | 11.7 | 4.6 to 18.8 |
| 55–74 | 23.0 | 19.6 to 26.4 | 24.4 | 21.2 to 27.6 | 31.1 | 28.8 to 33.5 | 25.8 | 22.7 to 28.8 | 35.5 | 31.2 to 39.8 | 14.9 | 9.8 to 20.0 |
| 75–99 | 10.9 | 7.6 to 14.2 | 12.6 | 8.9 to 16.3 | 16.2 | 13.4 to 18.9 | 11.1 | 8.4 to 13.7 | 22.3 | 16.7 to 27.9 | 13.4 | 2.9 to 24.0 |
| Missing stage | ||||||||||||
| All ages | 57.8 | 52.3 to 63.3 | 26.0 | 14.4 to 37.7 | 25.5 | 19.8 to 31.1 | 39.0 | 31.0 to 46.9 | 17.1 | 6.1 to 28.2 | 26.3 | 20.5 to 32.1 |
| Age-standardised | 57.8 | 53.9 to 61.7 | 26.8 | 19.3 to 34.3 | 26.7 | 22.7 to 30.7 | 37.5 | 32.1 to 42.9 | 16.9 | 9.6 to 24.1 | 25.6 | 21.4 to 29.7 |
| 15–54 | 75.7 | 67.9 to 83.5 | Not possible to estimate | 47.5 | 35.6 to 59.3 | 59.3 | 47.5 to 71.2 | 32.9 | 16.7 to 49.1 | 45.7 | 34.7 to 56.7 | |
| 55–74 | 62.4 | 56.7 to 68.1 | 31.7 | 18.9 to 44.5 | 30.2 | 23.6 to 36.8 | 43.6 | 35.0 to 52.3 | 22.0 | 8.5 to 35.5 | 29.8 | 22.9 to 36.7 |
| 75–99 | 44.8 | 37.6 to 52.0 | 15.4 | 5.1 to 25.7 | 14.4 | 9.1 to 19.6 | 21.3 | 13.0 to 29.6 | 6.3 | 0.0 to 13.1 | 12.9 | 7.7 to 18.1 |
*Australia: New South Wales.
†Canada: Alberta and Manitoba.
‡Sweden: Uppsala-Örebro and Stockholm-Gotland health regions.
§UK (TNM analysis): West Midlands Cancer Intelligence Unit Eastern Cancer Registration and Information Centre in England and Northern Ireland; UK (SEER analysis): Northern Ireland.